Brief: Cibus Achieves Additional Milestone For Gene Edits For Sclerotinia Resistance In Canola
Nov 14 (Reuters) - Cibus Inc CBUS.O :
* CIBUS ACHIEVES ADDITIONAL MILESTONE FOR NEXT GENERATION
GENE
EDITS FOR SCLEROTINIA RESISTANCE IN CANOLA
Source text: urn:newsml:reuters.com:*:nGNX4m1M9T
Further company coverage: CBUS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cibus
See all newsCibus Inc reports results for the quarter ended June 30 - Earnings Summary
Cibus Q2 revenue rises, loss narrows on cost cuts
Cibus Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Cibus Inc - To Offer Securities With Aggregate Initial Offering Price Up To $200 Million - SEC Filing
Cibus Q1 revenue rises and beats analyst estimates